» Articles » PMID: 31924228

Isotalatizidine, a C-diterpenoid Alkaloid, Attenuates Chronic Neuropathic Pain Through Stimulating ERK/CREB Signaling Pathway-mediated Microglial Dynorphin A Expression

Overview
Publisher Biomed Central
Date 2020 Jan 12
PMID 31924228
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Isotalatizidine is a representative C-diterpenoid alkaloid extracted from the lateral roots of Aconitum carmichaelii, which has been widely used to treat various diseases on account of its analgesic, anti-inflammatory, anti-rheumatic, and immunosuppressive properties. The aim of this study was to evaluate the analgesic effect of isotalatizidine and its underlying mechanisms against neuropathic pain.

Methods: A chronic constrictive injury (CCI)-induced model of neuropathic pain was established in mice, and the limb withdrawal was evaluated by the Von Frey filament test following isotalatizidine or placebo administration. The signaling pathways in primary or immortalized microglia cells treated with isotalatizidine were analyzed by Western blotting and immunofluorescence.

Results: Intrathecal injection of isotalatizidine attenuated the CCI-induced mechanical allodynia in a dose-dependent manner. At the molecular level, isotalatizidine selectively increased the phosphorylation of p38 and ERK1/2, in addition to activating the transcription factor CREB and increasing dynorphin A production in cultured primary microglia. However, the downstream effects of isotalatizidine were abrogated by the selective ERK1/2 inhibitor U0126-EtOH or CREB inhibitor of KG-501, but not by the p38 inhibitor SB203580. The results also were confirmed in in vivo experiments.

Conclusion: Taken together, isotalatizidine specifically activates the ERK1/2 pathway and subsequently CREB, which triggers dynorphin A release in the microglia, eventually leading to its anti-nociceptive action.

Citing Articles

5HT1R agonist alleviates presurgical prolonged sleep deprivationinduced postsurgical pain in adolescent mice.

Zhu W, Xu X, Xu R, Huang Y, Ma Z Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(10):1543-1555.

PMID: 40074303 PMC: 11897974. DOI: 10.11817/j.issn.1672-7347.2024.240499.


Electroacupuncture produces analgesic effects via cannabinoid CB1 receptor-mediated GABAergic neuronal inhibition in the rostral ventromedial medulla.

Wan K, Xu Q, Shi Y, Cui C, Lei J, Zhang K Chin Med. 2025; 20(1):30.

PMID: 40038719 PMC: 11881457. DOI: 10.1186/s13020-025-01083-4.


A comprehensive review of traditional Chinese medicine in treating neuropathic pain.

Hu N, Liu J, Luo Y, Li Y Heliyon. 2024; 10(17):e37350.

PMID: 39296122 PMC: 11407996. DOI: 10.1016/j.heliyon.2024.e37350.


Neuropharmacological Potential of Diterpenoid Alkaloids.

Salehi A, Ghanadian M, Zolfaghari B, Jassbi A, Fattahian M, Reisi P Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242531 PMC: 10223254. DOI: 10.3390/ph16050747.


Epiisopiloturine, an Alkaloid from , Attenuates LPS-Induced Neuroinflammation by Interfering in the TLR4/NF-B-MAPK Signaling Pathway in Microglial Cells.

de Sousa J, Azul F, de Araujo A, Tome R, Silva F, de Vasconcelos S Oxid Med Cell Longev. 2023; 2023:4752502.

PMID: 37151606 PMC: 10162877. DOI: 10.1155/2023/4752502.


References
1.
Frank D, Greenberg M . CREB: a mediator of long-term memory from mollusks to mammals. Cell. 1994; 79(1):5-8. DOI: 10.1016/0092-8674(94)90394-8. View

2.
Canon E, Cosgaya J, Scsucova S, Aranda A . Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol Biol Cell. 2004; 15(12):5583-92. PMC: 532036. DOI: 10.1091/mbc.e04-05-0439. View

3.
Kawasaki Y, Zhang L, Cheng J, Ji R . Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008; 28(20):5189-94. PMC: 2408767. DOI: 10.1523/JNEUROSCI.3338-07.2008. View

4.
Stein C, Machelska H . Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev. 2011; 63(4):860-81. DOI: 10.1124/pr.110.003145. View

5.
Brust A, Croker D, Colless B, Ragnarsson L, Andersson A, Jain K . Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties. J Med Chem. 2016; 59(6):2381-95. DOI: 10.1021/acs.jmedchem.5b00911. View